The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies
|
|---|---|
| Published in |
Frontiers in Pharmacology, September 2023
|
| DOI | 10.3389/fphar.2023.1264961 |
| Pubmed ID | |
| Authors |
Amir Taldaev, Roman Terekhov, Ilya Nikitin, Elizaveta Melnik, Vera Kuzina, Mikhail Klochko, Igor Reshetov, Artem Shiryaev, Victor Loschenov, Galina Ramenskaya |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 10% |
| Unknown | 18 | 90% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 85% |
| Practitioners (doctors, other healthcare professionals) | 3 | 15% |
Mendeley readers
The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 18 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 4 | 22% |
| Researcher | 3 | 17% |
| Student > Master | 1 | 6% |
| Student > Bachelor | 1 | 6% |
| Other | 1 | 6% |
| Other | 0 | 0% |
| Unknown | 8 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 5 | 28% |
| Biochemistry, Genetics and Molecular Biology | 2 | 11% |
| Materials Science | 2 | 11% |
| Engineering | 1 | 6% |
| Unknown | 8 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2024.
All research outputs
#2,569,816
of 26,571,961 outputs
Outputs from Frontiers in Pharmacology
#1,123
of 20,608 outputs
Outputs of similar age
#43,032
of 367,990 outputs
Outputs of similar age from Frontiers in Pharmacology
#14
of 687 outputs
Altmetric has tracked 26,571,961 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,608 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,990 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 687 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.